- Home
- BLRX vs PPSI Comparison
BLRX vs PPSI Comparison
Compare BLRX & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- PPSI
- Stock Information
- Founded
- BLRX 2003
- PPSI 2008
- Country
- BLRX Israel
- PPSI United States
- Employees
- BLRX N/A
- PPSI N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- PPSI Electrical Products
- Sector
- BLRX Health Care
- PPSI Industrials
- Exchange
- BLRX Nasdaq
- PPSI Nasdaq
- Market Cap
- BLRX 54.1M
- PPSI 65.0M
- IPO Year
- BLRX 2011
- PPSI N/A
- Fundamental
- Price
- BLRX $0.49
- PPSI $5.98
- Analyst Decision
- BLRX Strong Buy
- PPSI Strong Buy
- Analyst Count
- BLRX 2
- PPSI 2
- Target Price
- BLRX $11.50
- PPSI $10.50
- AVG Volume (30 Days)
- BLRX 320.6K
- PPSI 125.1K
- Earning Date
- BLRX 11-18-2024
- PPSI 11-12-2024
- Dividend Yield
- BLRX N/A
- PPSI N/A
- EPS Growth
- BLRX N/A
- PPSI N/A
- EPS
- BLRX N/A
- PPSI N/A
- Revenue
- BLRX $17,048,000.00
- PPSI $34,585,000.00
- Revenue This Year
- BLRX N/A
- PPSI $30.45
- Revenue Next Year
- BLRX N/A
- PPSI $37.55
- P/E Ratio
- BLRX N/A
- PPSI N/A
- Revenue Growth
- BLRX N/A
- PPSI N/A
- 52 Week Low
- BLRX $0.43
- PPSI $3.35
- 52 Week High
- BLRX $1.93
- PPSI $7.30
- Technical
- Relative Strength Index (RSI)
- BLRX 34.05
- PPSI 74.38
- Support Level
- BLRX $0.43
- PPSI $4.68
- Resistance Level
- BLRX $0.56
- PPSI $6.00
- Average True Range (ATR)
- BLRX 0.05
- PPSI 0.34
- MACD
- BLRX -0.01
- PPSI 0.14
- Stochastic Oscillator
- BLRX 23.96
- PPSI 91.87
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc manufactures, sells, and services a broad range of specialty electrical transmission, distribution, and on-site power generation equipment for applications in the utility, industrial, commercial and backup power markets. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets. Pioneer Power works in two reportable segments which includes Electrical Infrastructure Equipment and Critical Power Solutions (Critical Power). Pioneer generates the majority of its revenue from the United States of America.